ATI PHARMACOLOGY 2019 PROCTORED EXAM –LATEST
REVISED EDITION-2023 WITH 100% CORRECT ANSWERS.
GRADED A. (NGN) QUESTIONS INCLUDED lOMoARcPSD|13564786
1. When Vadministering Vthe Vdrug Vsenna Vto Va Vpatient, Va Vhealth Vcare Vprovider Vmust
Vinform Vthe Vpatient Vof Vwhich Vof Vthe Vfollowing
a. This Vdrug Vis Vintended Vto Vlower Vblood Vpressure Vand Vis Vbest Vused Vin
Vcombination Vwith Vother Vantihypertensives
b. This Vdrug Vis Vnot Vintended Vfor Vlong Vterm Vuse
c. The Vpatient Vmust Vlimit Vhis/her Vfiber Vintake
d. Advise Vpatient Vto Vchange Vpositions Vslowly Vto Vlimit Vthe Vrisk
Vof Vorthostatic Vhypotension
2. When Vgiving Vdigoxin V(Lanoxin) Vto Va Vpatient, Vthe Vhealth Vcare Vprovider Vnotices Vvarious
Vsigns Vand Vsymptoms Vof Van Voverdose. VThe Vhealth Vcare Vprovider Vknows Vto Vgive Vwhich Vof
Vthe Vfollowing Vto Vreverse Vdigoxin Vtoxicity
a. Naloxone
b. Vitamin
VK Vc.
V Digibind
d. VFluemanzil
3. While Vproviding Van VAngiotensin-converting Venzyme V(ACE) Vinhibitor, Vthe Vpatient Vasks
Vwhat Vthe Vaction Vof Vthe Vdrug Vis. VAs Va Vhealth Vcare Vprovider, Vyou Vexplain Vthat Vthe
Vaction Vof Van VACE Vinhibitor Vis
a. To Vlower Vblood Vpressure Vby Vblocking Vthe Vconversion Vof
Vangiotensin VI Vto Vvasoconstrictor Vangiotensin VII
b. To Vinhibit Vreabsorption Vof Vsodium Vback Vinto Vthe Vbody, Vultimately
Vincreasing Vurine Voutput Vand Vlowering Vblood Vpressure
c. To Vdecrease Vheart Vrate Vand Vblood Vpressure Vby Vcompeting Vwith VBeta1 Vand
VBeta2 Vreceptors Vin Vthe Vheart Vand Vlungs
d. To Vlower Vblood Vglucose Vby Vstimulating Vthe Vrelease Vof Vinsulin
4. Which Vof Vthe Vfollowing Vtypes Vof Vinsulin Vis V“long-acting”?
a. Lispro V(Humalog)
b. NPH V(Humulin VN)
c. Regular Vinsulin V(Humulin
VR) Vd. V Glargine V(Lantus)
1. What Vis Vthe Vtherapeutic Vuse Vof Vmetformin?
A. Lower Vblood Vpressure.
B. To Vdiminish Vseizure Vactivity.
C. The Vmaintenance Vof Va Vperson’s Vblood Vglucose.
D. Increase Vheart Vrate Vand Vdecrease Vgastrointestinal Vsecretions.
, ATI PHARMACOLOGY 2019 PROCTORED
V V V
1. What Vis Vthe Vcorrect Vdefinition Vfor Vabsorption Vof Va Vdrug?
A. Movement Vof Vdrug Vfrom Vsite Vof Vadministration Vto Vvarious Vtissues Vof Vthe Vbody.
B. Describes Vthe Vabsorption, Vdistribution, Vmetabolism V& Vexcretion Vof Vdrugs.
C. These Vtypes Vof Vdrugs Vcan Vbe Vtaken Vover Vthe Vcounter.
D. This Vaddresses Vhow Vvarious Vdrugs Vaffect Vdifferent Vforms Vof Vthe Vbody.
2. What Vdo Vyou Vassess Vfor Vin Va Vpatient Vwho Vis Von VValproate? VSelect
Vall Vthat Vapply. VA. V Suicidal Vthoughts
B. VMonitor Vfor
Vseizures. VC. V Bipolar
Vdisorder.
D. VMigraines.
3. What Vis Vtrue Vabout Vfood Vand Vdrug Vprecautions? VSelect Vall Vthat Vapply.
A. You Vmust Vlimit Vcertain Vtypes Vof Vfood Vor Vconcurrent Vadministration Vof
Vcertain Vtypes Vof Vdrugs.
B. Certain Vcombinations Vof Vfood Vand Vdrugs Vcan Vcause Vadverse Vreactions.
C. Precautions Vmay Vrequire Vlimiting Vcertain Vtypes Vof Vfood Vor Vconcurring Vdrugs
Vrather Vthan Vrestricting Vthe Vdrug Vitself.
D. When Vone Vdrug Vchanges Vthe Vway, Vanother Vdrug Vaffects Vthat Vdrug.
1. ACE VInhibitors Vare Vused Vin Vthe Vtreatment Vof Vall VEXCEPT:
a. Hypertension
b. Heart
VFailure Vc.
V Hypotension
d. V Diabetic Vnephropathy
2. Which Vof Vthe Vfollowing Vis Vused Vto
Vtreat Vmigraine Vheadaches? Va. V Beta-
blockers
b. Cholinesterase VInhibitors
c. ACE Vinhibitors
d. Anti-epileptic Vdrugs V(AEDs)
3. When Vadministering Va VSerotonin VAntagonist Vit Vis Vimportant Vto Vmonitor Vfor
a. Intake Vand Voutput
b. Mental Vstatus Vchanges
c. Respiratory Vrate
d. Anorexia
4. Which Vof Vthe Vfollowing Vis Vthe Vantidote
Vfor VHeparin? Va. V Protamine Vsulfate
, ATI PHARMACOLOGY 2019 PROCTORED
V V V
b. Vitamin VK
c. Naloxone
d. Toradol
1. A Vpatient Vhas Vbeen Vtaking Vhydrocodone, Vand Vopioid Vanalgesic V for Vtheir Vmoderate
Vpain, Vand Vthey Vhave Vtaken Vover Vtheir Vprescribed Vdose. VWhat Vshould Vyou Vgive Vas Vthe
Vantidote Vif Vthey Vexperience Vtoxicity?
A. Naloxone
B. N-acetylcysteine
C. Atropine
D. Digoxin Vimmune VFab
1. A Vpatient Vis Vbeing Veducated Von Vtaking Vlevothyroxine, Va Vdrug Vused Vto
Vbalance Vthyroid Vactivity. VWhat Vshould Vyou Vinclude Vin Vtheir Veducation?
C. Thyroid Vtests Vare Vunnecessary Vwhile Vtaking Vthis Vdrug
D. It Vis Vokay Vto Vtake Vthis Vdrug Vif Vyou Vhave Vrecently Vhad Va Vmyocardial Vinfarction
1. A Vpatient Vstates Vhe Vexperiences Vanxiety Vand Vhas Vpanic Vattacks Vat Vleast Vonce Va Vweek.
VWhat Vmight Vbe Vhelpful Vfor V this Vpatient?
A. Phenytoin V(Dilantin)
B. Lithium
C. Alprazolam V(Xanax)
D. Spironolactone
1. Which Vof Vthe Vfollowing Vis VNOT Van Vopioid Vor VNSAID?
A. Morphine
B. Ibuprofen
C. Hydromorphone
VD. V Acetaminophen
1) Why Vis Vit Vimportant Vto Vmonitor Vins Vand Vouts Vwith Vpatients Vusing VACE Vinhibitors?
A. To Vassess Vfor Vrenal Vimpairment
B. You Vmust Vmake Vsure Vthe Vpatient Vis Vreceiving Vadequate Vfluid Vintake
C. To Vassess Vthe Vpatient Vfor Vpotential Vheart Vfailure
D. You Vmust Vassess Vfor VNSAID Vuse
E. To Vassess Vfor Vdecreased Vblood Vpressure
, ATI PHARMACOLOGY 2019 PROCTORED
V V V
2) Which Vdrug Vgoes Vthrough Vextensive Vfirst-pass Vhepatic Vmetabolism?
A. Heparin
B. Insulin
C. Propranolol
D. Nitroglycerine
E. Warfarin
3) What Vnursing Vinterventions Vshould Vyou Vdo Vwhen Va Vpatient Vis Von VAlbuterol
V(select Vall Vthat Vapply)
A. Assess Vlung Vsounds, VPulse, Vand VBlood Vpressure Vbefore Vadministering
B. Monitor Vfor Vchanges Vin Vbehavior
C. Observe Vfor Vparadoxical Vbronchospasms
D. Assess Vfor Vabdominal Vdistention
E. Note Vsputum Vcolor Vand Vtexture
4) What Vpatient Vcould Vpotentially Vtake Vthe Vdrug VSenna?
A. A Vpatient Vwith Van Veating Vdisorder
B. A Vpatient Vwho Vhas Vnot Vpassed Vstool Vin V5 Vdays
C. A Vpatient Vwith Vanal Vfissures
D. A Vpatient Vwith Va Vhistory Vof Vhemorrhoids
E. A Vpatient Vwho Vhas Vhypersensitivity
Question V#1
What Vis Vthe Vcategory Vclass Vof VLithium?
A. VAntidiabetics,
Vbiguanides VB. V Mood
Vstabilizers
C. V Antiarrhythmics, Vanticonvulsants
D. V Vascular Vheadache Vsuppressants
Question V#2
What Vdo Vyou Vneed Vto Vteach Vyour Vpatient Vif Vthey Vare Vtaking Vsennosides? VSelect VAll
VThat VApply.
A. Laxatives Vshould Vbe Vused Vfor Vshort-term Vtherapy
B. The Vmedication Vdoes Vnot Vcure Vhypothyroidism
C. The Vcolor Vof Vthe Vurine Vmay Vchange Vto Va Vpink, Vred, Vviolet, Vyellow, Vor
Vbrown VD. VMake Vsure Vother Vforms Vof Vbowel Vregulation Vare Vbeing Vused
Question V#3
What Vis Vthe Vtherapeutic Vuse Vof VPhenytoin?
A. Replacement Vin Vhypothyroidism Vto Vrestore Vnormal Vhormonal Vbalance
B. Diminished Vaccumulation Vof Vacid Vin Vthe Vgastric Vlumen Vwith Vlessened
Vgastroesophageal Vreflux
C. Diminished Vseizure Vactivity, Vtermination Vof Vventricular Varrhythmias
D. Prevention Vof Vthrombus Vformation, Vprevention Vof Vextension Vof Vexisting Vthrombi
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller Ascorers. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $16.49. You're not tied to anything after your purchase.
